NOV 11, 2015 01:30 PM PST

Why to validate diagnostic tests?

Speakers
  • Associate Professor, University of Texas Health Science Center at San Antonio
    Biography
      I graduated from the Collegium Medicum at Jagiellonski University in Poland, and subsequently completed residency program in anatomic, clinical pathology and clinical chemistry. I have been practicing pathology in the University of Texas Health Science Center at San Antonio, Texas as a staff pathologist and medical director of clinical chemistry and molecular laboratory.
      I have been serving the Instrumental Resource Committee of the College of American Pathologist (CAP) since 2008. Since 2009 I have served for the Pharmacogenomics Committee, Educational subcommittee working on Pharmacogenomics Educational Course. I was actively involved in the CLSI on a project "Method Validation by using patient's sample". The main scientific interest is in biomarkers for aggressive prostate cancer as well as biomarkers for monitoring the trauma patients with hemorrhagic shock.

    Abstract:

    This lecture will provide attendees with the knowledge and skills to bring on new clinical laboratory tests in clinical chemistry and molecular diagnostics. The lecture will provide a general overview of the CLIA and CAP regulatory requirements for the implementation of new tests, including conducting test validation, discussing the analytical measurement range (as appropriate for quantitative assays), cut offs for qualitative tests and carry over identification. The lecture will discuss some examples from the areas of clinical chemistry and molecular diagnostics which are related the general principles of validation.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    Loading Comments...